EE200000627A - Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks - Google Patents

Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks

Info

Publication number
EE200000627A
EE200000627A EEP200000627A EEP200000627A EE200000627A EE 200000627 A EE200000627 A EE 200000627A EE P200000627 A EEP200000627 A EE P200000627A EE P200000627 A EEP200000627 A EE P200000627A EE 200000627 A EE200000627 A EE 200000627A
Authority
EE
Estonia
Prior art keywords
investigation
bone
expression vector
kidney disease
promoter dna
Prior art date
Application number
EEP200000627A
Other languages
English (en)
Estonian (et)
Inventor
Kawai Shinji
Sugiura Takeyuki
Original Assignee
Hoechst Marion Roussel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel filed Critical Hoechst Marion Roussel
Publication of EE200000627A publication Critical patent/EE200000627A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200000627A 1998-04-30 1999-04-22 Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks EE200000627A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10120174A JPH11313675A (ja) 1998-04-30 1998-04-30 ヒトbmp−7プロモーターおよびこれを用いた骨関連物質の探索法
PCT/IB1999/000733 WO1999057293A1 (en) 1998-04-30 1999-04-22 Human bmp-7 promoter and method for exploring bone-related substance by using the same

Publications (1)

Publication Number Publication Date
EE200000627A true EE200000627A (et) 2002-02-15

Family

ID=14779761

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000627A EE200000627A (et) 1998-04-30 1999-04-22 Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks

Country Status (26)

Country Link
US (2) US6534268B1 (ru)
EP (1) EP1076713A1 (ru)
JP (1) JPH11313675A (ru)
KR (1) KR20010071193A (ru)
CN (1) CN1170941C (ru)
AP (1) AP1329A (ru)
AU (1) AU769124B2 (ru)
BG (1) BG64780B1 (ru)
BR (1) BR9910585A (ru)
CA (1) CA2326957A1 (ru)
EA (1) EA004509B1 (ru)
EE (1) EE200000627A (ru)
GE (1) GEP20033056B (ru)
HR (1) HRP20000736A2 (ru)
HU (1) HUP0102329A3 (ru)
ID (1) ID26704A (ru)
IL (1) IL139100A0 (ru)
NO (1) NO20005433L (ru)
NZ (1) NZ507625A (ru)
PL (1) PL343817A1 (ru)
SK (1) SK16082000A3 (ru)
TR (1) TR200003182T2 (ru)
UA (1) UA72212C2 (ru)
WO (1) WO1999057293A1 (ru)
YU (1) YU64900A (ru)
ZA (1) ZA200006080B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US20070015701A1 (en) * 2005-06-01 2007-01-18 Samuel Zalipsky Macromolecular conjugates of bone morphogenetic protein-7
ES2432395T3 (es) * 2006-10-12 2013-12-03 Ethicon, Inc. Células derivadas de riñon y metodo de uso en la reparación y regeneración tisular
EP2293808B1 (en) * 2008-05-16 2012-08-15 Industry Foundation Of Chonnam National University An synthetic peptide containing bone forming peptide 1(bfp 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide
US20110305898A1 (en) 2010-06-09 2011-12-15 Zheng Zhang Non-fouling, anti-microbial, anti-thrombogenic graft compositions
NZ603705A (en) 2010-06-09 2014-10-31 Semprus Biosciences Corp Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions
WO2011156603A2 (en) 2010-06-09 2011-12-15 Semprus Biosciences Corp. Articles having non-fouling surfaces and processes for preparing the same without altering bulk physical properties
CA3052927C (en) 2010-08-18 2023-01-03 Scott D. Boden Compounds and compositions for ossification and methods related thereto
WO2012116137A2 (en) 2011-02-24 2012-08-30 Emory University Jab1 blocking compositions for ossification and methods related thereto
CA2827392A1 (en) 2011-02-24 2012-08-30 Emory University Noggin blocking compositions for ossification and methods related thereto
CA2858730C (en) 2011-12-14 2017-07-18 Semprus Biosciences Corp. Surface modified contact lenses
WO2013115917A1 (en) 2011-12-14 2013-08-08 Semprus Biosciences Corp. Imbibing process for contact lens surface modification
US9000063B2 (en) 2011-12-14 2015-04-07 Semprus Biosciences Corporation Multistep UV process to create surface modified contact lenses
WO2013090813A1 (en) 2011-12-14 2013-06-20 Semprus Biosciences Corp. Redox processes for contact lens modification
MX2014007211A (es) 2011-12-14 2015-04-14 Semprus Biosciences Corp Lente de contacto de hidrogel de silicona modificada usando oxidantes de lantanido o de metal de transicion.
WO2019005563A1 (en) * 2017-06-27 2019-01-03 St. Jude Children's Research Hospital METHODS ASSOCIATED WITH THE ACTIVATION OF THE SIGNALING PATHWAY OF BONE MORPHOGENETIC PROTEINS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
DK0429570T3 (da) 1989-03-28 1998-04-27 Genetics Inst Osteoinducerende præparater
US5650276A (en) * 1991-03-11 1997-07-22 Creative Biomolecules, Inc. Morphogenic protein screening method
WO1993003382A2 (en) * 1991-08-01 1993-02-18 Pharmaceutical Discovery Corporation Characterization of specific drug receptors with fluorescent ligands
AU703445B2 (en) * 1994-06-07 1999-03-25 Stryker Corporation Methods and compositions for modulating morphogenic protein expression
US6083690A (en) * 1995-06-02 2000-07-04 Osteoscreen, Inc. Methods and compositions for identifying osteogenic agents
AU5558498A (en) 1996-11-22 1998-06-22 Akzo Nobel N.V. Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
US5863790A (en) 1997-05-14 1999-01-26 Minnesota Mining And Manfacturing Company Biological sterility indicator
AU745514B2 (en) * 1997-05-29 2002-03-21 Curis, Inc. Modulators of morphogen expression and methods of identifying the same

Also Published As

Publication number Publication date
CN1170941C (zh) 2004-10-13
KR20010071193A (ko) 2001-07-28
GEP20033056B (en) 2003-08-25
AP1329A (en) 2004-11-22
AP2000001982A0 (en) 2000-12-31
AU769124B2 (en) 2004-01-15
ZA200006080B (en) 2001-10-29
US6534268B1 (en) 2003-03-18
YU64900A (sh) 2003-10-31
EP1076713A1 (en) 2001-02-21
CN1307643A (zh) 2001-08-08
AU3163499A (en) 1999-11-23
EA004509B1 (ru) 2004-04-29
JPH11313675A (ja) 1999-11-16
NO20005433D0 (no) 2000-10-27
ID26704A (id) 2001-02-01
HUP0102329A2 (hu) 2001-10-28
CA2326957A1 (en) 1999-11-11
IL139100A0 (en) 2001-11-25
BG104883A (en) 2001-05-31
TR200003182T2 (tr) 2001-02-21
PL343817A1 (en) 2001-09-10
BR9910585A (pt) 2001-01-09
HRP20000736A2 (en) 2001-10-31
BG64780B1 (bg) 2006-03-31
HUP0102329A3 (en) 2006-03-28
WO1999057293A1 (en) 1999-11-11
NO20005433L (no) 2000-10-27
UA72212C2 (en) 2005-02-15
EA200001130A1 (ru) 2001-04-23
SK16082000A3 (sk) 2001-05-10
NZ507625A (en) 2003-12-19
US20030040007A1 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
EE200000627A (et) Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
AU2002216273A1 (en) Proteins, genes and their use for diagnosis and treatment of kidney response
WO2003055443A3 (en) Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
DE69830087D1 (de) Gerät zur therapeutischen Kauterisation von vorbestimmten Volumen biologischen Gewebes
WO2001066596A3 (en) Human fgf-23 gene and gene expression products
ID23218A (id) Metoda pengobatan gagal jantung
WO2003089608A3 (en) Drg11-responsive (dragon) gene family
SG121733A1 (en) Nucleic acid molecules polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
ZA965565B (en) Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits.
WO2002022871A3 (en) Polymorphic bone morphogenetic protein 2
EA200101260A1 (ru) Способ изменения физико-химических и/или биологических свойств вещества
EP0805206A3 (en) Human cartilage glycoprotein
WO2002046767A3 (en) Diagnosis and treatment of alzheimer's disease
BR9712767A (pt) Expressão especìfica para tecido de proteìna de retinoblastoma
DE69831223D1 (de) Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52
AU2001233954A1 (en) Proteins, genes and their use for diagnosis and treatment of schizophrenia
EE200000631A (et) Inimese BMP-4 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudaine uurimiseks
WO2001083524A3 (en) Rna metabolism proteins
AU2001240820A1 (en) Proteins, genes and their use for diagnosis and treatment of vascular dementia
EA200100544A1 (ru) Способ экспресс-диагностики физиологического состояния биологического объекта и устройство для его осуществления
WO2002016587A3 (en) Microtubule-associated proteins and tubulins
WO2002034282A3 (en) Mammary secreted protein 36 (msp36) for cancer treatment and diagnosis
AU2002222308A1 (en) Proteins, genes and their use for diagnosis and treatment of vascular response

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner